203 related articles for article (PubMed ID: 30987181)
1. IMM-H004 Protects against Cerebral Ischemia Injury and Cardiopulmonary Complications via CKLF1 Mediated Inflammation Pathway in Adult and Aged Rats.
Ai Q; Chen C; Chu S; Luo Y; Zhang Z; Zhang S; Yang P; Gao Y; Zhang X; Chen N
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987181
[TBL] [Abstract][Full Text] [Related]
2. IMM-H004 therapy for permanent focal ischemic cerebral injury via CKLF1/CCR4-mediated NLRP3 inflammasome activation.
Ai QD; Chen C; Chu S; Zhang Z; Luo Y; Guan F; Lin M; Liu D; Wang S; Chen N
Transl Res; 2019 Oct; 212():36-53. PubMed ID: 31176667
[TBL] [Abstract][Full Text] [Related]
3. IMM-H004 protects against oxygen-glucose deprivation/reperfusion injury to BV2 microglia partly by modulating CKLF1 involved in microglia polarization.
Chen C; Ai Q; Chu S; Zhang Z; Zhou X; Luo P; Liu Y; Chen N
Int Immunopharmacol; 2019 May; 70():69-79. PubMed ID: 30785093
[TBL] [Abstract][Full Text] [Related]
4. Compound IMM-H004, a novel coumarin derivative, protects against CA1 cell loss and spatial learning impairments resulting from transient global ischemia.
Zuo W; Zhang W; Han N; Chen NH
CNS Neurosci Ther; 2015 Mar; 21(3):280-8. PubMed ID: 25601434
[TBL] [Abstract][Full Text] [Related]
5. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N
Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933
[TBL] [Abstract][Full Text] [Related]
6. IMM-H004, A New Coumarin Derivative, Improved Focal Cerebral Ischemia via Blood-Brain Barrier Protection in Rats.
Niu F; Song XY; Hu JF; Zuo W; Kong LL; Wang XF; Han N; Chen NH
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2065-2073. PubMed ID: 28669655
[TBL] [Abstract][Full Text] [Related]
7. Upregulating the Expression of Survivin-HBXIP Complex Contributes to the Protective Role of IMM-H004 in Transient Global Cerebral Ischemia/Reperfusion.
Chu SF; Zhang Z; Zhang W; Zhang MJ; Gao Y; Han N; Zuo W; Huang HY; Chen NH
Mol Neurobiol; 2017 Jan; 54(1):524-540. PubMed ID: 26742528
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of chemokine-like factor 1, a novel C-C chemokine, protects against focal cerebral ischemia by inhibiting neutrophil infiltration via MAPK pathways in rats.
Kong LL; Wang ZY; Han N; Zhuang XM; Wang ZZ; Li H; Chen NH
J Neuroinflammation; 2014 Jun; 11():112. PubMed ID: 24946684
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of chemokine-like factor 1 improves blood-brain barrier dysfunction in rats following focal cerebral ischemia.
Kong LL; Wang ZY; Hu JF; Yuan YH; Li H; Chen NH
Neurosci Lett; 2016 Aug; 627():192-8. PubMed ID: 27283776
[TBL] [Abstract][Full Text] [Related]
10. IMM-H004, a Novel Coumarin Derivative Compound, Inhibits H
Song XY; Hu JF; Wu DH; Ji HJ; Chen NH
J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3396-3403. PubMed ID: 30243729
[TBL] [Abstract][Full Text] [Related]
11. IMM-H004, a novel courmarin derivative, protects against oxygen-and glucose-deprivation/restoration-induced apoptosis in PC12 cells.
Ji HJ; Wang DM; Hu JF; Sun MN; Li G; Li ZP; Wu DH; Liu G; Chen NH
Eur J Pharmacol; 2014 Jan; 723():259-66. PubMed ID: 24291097
[TBL] [Abstract][Full Text] [Related]
12. A new coumarin derivative, IMM-H004, attenuates okadaic acid-induced spatial memory impairment in rats.
Song XY; Wang YY; Chu SF; Hu JF; Yang PF; Zuo W; Song LK; Zhang S; Chen NH
Acta Pharmacol Sin; 2016 Apr; 37(4):444-52. PubMed ID: 26838073
[TBL] [Abstract][Full Text] [Related]
13. IMM-H004, a novel coumarin derivative compound, protects against amyloid beta-induced neurotoxicity through a mitochondrial-dependent pathway.
Song XY; Hu JF; Sun MN; Li ZP; Wu DH; Ji HJ; Yuan YH; Zhu ZX; Han N; Liu G; Chen NH
Neuroscience; 2013 Jul; 242():28-38. PubMed ID: 23523945
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of chemokine-like factor 1 protects against focal cerebral ischemia through the promotion of energy metabolism and anti-apoptotic effect.
Kong LL; Wang ZY; Hu JF; Yuan YH; Han N; Li H; Chen NH
Neurochem Int; 2014 Oct; 76():91-8. PubMed ID: 25042180
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg1 treats ischemic stroke by regulating CKLF1/CCR5 axis-induced neuronal cell pyroptosis.
Long J; Sun Y; Liu S; Chen C; Yan Q; Lin Y; Zhang Z; Chu S; Yang Y; Yang S; Lin M; Liu X; Liang J; Chen N; Ai Q
Phytomedicine; 2024 Jan; 123():155238. PubMed ID: 38128394
[TBL] [Abstract][Full Text] [Related]
16. Expression of chemokine-like factor 1 after focal cerebral ischemia in the rat.
Kong LL; Hu JF; Zhang W; Yuan YH; Ma KL; Han N; Chen NH
Neurosci Lett; 2011 Nov; 505(1):14-8. PubMed ID: 21964493
[TBL] [Abstract][Full Text] [Related]
17. Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux.
Chen C; Ai QD; Wei YH
J Ethnopharmacol; 2021 Jan; 264():113388. PubMed ID: 32918990
[TBL] [Abstract][Full Text] [Related]
18. CKLF1 Aggravates Focal Cerebral Ischemia Injury at Early Stage Partly by Modulating Microglia/Macrophage Toward M1 Polarization Through CCR4.
Chen C; Chu SF; Ai QD; Zhang Z; Guan FF; Wang SS; Dong YX; Zhu J; Jian WX; Chen NH
Cell Mol Neurobiol; 2019 Jul; 39(5):651-669. PubMed ID: 30982091
[TBL] [Abstract][Full Text] [Related]
19. Determination of IMM-H004 and its active glucuronide metabolite in rat plasma and Ringer's solution by ultra-performance liquid chromatography-tandem mass spectrometry.
Jiang J; Zhang Z; Zou X; Wang R; Bai J; Zhao S; Fan X; Sheng L; Li Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1074-1075():16-24. PubMed ID: 29329091
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CKLF1 ameliorates hepatic ischemia-reperfusion injury via MAPK pathway.
Li FF; Zhou X; Chu SF; Chen NH
Cytokine; 2021 May; 141():155429. PubMed ID: 33578361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
